- Home
- ARWR vs FRHC Comparison
ARWR vs FRHC Comparison
Compare ARWR & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | FRHC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.3B |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ARWR | FRHC |
|---|---|---|
| Price | $59.98 | $187.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $107.71 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 74.0K |
| Earning Date | 11-24-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | 79.29 |
| EPS | N/A | ★ 0.52 |
| Revenue | $16,142,321.00 | ★ $2,191,291,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $358.15 |
| Revenue Growth | N/A | ★ 6.86 |
| 52 Week Low | $37.06 | $107.98 |
| 52 Week High | $95.49 | $186.61 |
Technical Indicators
Market Signals| Indicator | ARWR | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 65.67 |
| Support Level | $54.93 | $164.04 |
| Resistance Level | $66.37 | N/A |
| Average True Range (ATR) | 2.22 | 6.51 |
| MACD | 0.91 | 1.21 |
| Stochastic Oscillator | 71.90 | 88.57 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other. The majority of revenue is from the Banking segment. Banking segment consists of the operations of Freedom Bank KZ and Freedom Bank TJ. Geographically, operates in Kazakhstan, Armenia, Cyprus, the USA, and others, with maximum revenue from Kazakhstan.